Page last updated: 2024-08-23

tolrestat and Diabetic Angiopathies

tolrestat has been researched along with Diabetic Angiopathies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, K; Corbett, JA; Currie, MG; Hasan, KS; McDaniel, ML; Misko, TP; Moore, WM; Petrash, JM; Smith, SR; Tilton, RG1
Tomlinson, DR1
Allison, W; Chang, K; Eades, D; Kilo, C; Ostrow, E; Sherman, WR; Williamson, JR1
Kador, PF; Kinoshita, JH; Sharpless, NE1

Reviews

2 review(s) available for tolrestat and Diabetic Angiopathies

ArticleYear
Aldose reductase inhibitors and the complications of diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 1993, Volume: 10, Issue:3

    Topics: Aldehyde Reductase; Animals; Cataract; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Humans; Kidney; Naphthalenes; Rats

1993
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:7

    Topics: Aldehyde Reductase; Animals; Binding Sites; Blood Glucose; Cataract; Chemical Phenomena; Chemistry; Corneal Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Models, Animal; Fluorenes; Galactose; Humans; Hydantoins; Imidazoles; Imidazolidines; Models, Molecular; Naphthalenes; Phthalazines; Rhodanine; Sorbitol; Structure-Activity Relationship; Substrate Specificity; Sugar Alcohol Dehydrogenases; Thiazolidines; Tissue Distribution

1985

Other Studies

2 other study(ies) available for tolrestat and Diabetic Angiopathies

ArticleYear
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
    Diabetes, 1993, Volume: 42, Issue:2

    Topics: Aldehyde Reductase; Amino Acid Oxidoreductases; Animals; Arginine; Benzothiazoles; Blood Pressure; Body Weight; Capillary Permeability; Citrulline; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Guanidines; Imidazoles; Imidazolidines; Inositol; Iodine Radioisotopes; Male; Methylguanidine; Naphthalenes; Nitric Oxide Synthase; omega-N-Methylarginine; Phthalazines; Rats; Rats, Sprague-Dawley; Retina; Sciatic Nerve; Serum Albumin, Bovine; Sorbitol; Thiazoles; Uvea

1993
Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
    The Journal of clinical investigation, 1990, Volume: 85, Issue:4

    Topics: Aldehyde Reductase; Animals; Capillary Permeability; Diabetic Angiopathies; Glucose; Glycosylation; Male; Microcirculation; Naphthalenes; Rats; Rats, Inbred Strains; Serum Albumin; Sorbitol; Stereoisomerism; Sugar Alcohol Dehydrogenases

1990